Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2017
Price : $35 *
At a glance
- Drugs NPB 06 (Primary)
- Indications Venous thrombosis
- Focus Registrational; Therapeutic Use
- Sponsors Nihon Pharmaceutical
- 24 Oct 2017 Primary endpoint (The proportion of patients obtained complete recanalization or partial recanalization of portal vein thrombosis) has been met, according to results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
- 07 Sep 2016 Status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History